Samada Research is focused on the development of safer advanced medicines and dietary aides.  

Samada Research has:

proprietary processes that are currently used commercially to identify and remove potential carcinogens in pharmaceutical compositions

 a promising abuse-resistant non-addictive opiate based analgesic agent  (CC-408) in preclinical development 

BACE I inhibitor leads for delaying the onset and progression of Alzheimer’s disease